Which drug wins for lupus kidney disease? new study pits telitacicept against belimumab
Disease control
Completed
This study looked back at medical records of 56 adults with lupus nephritis to compare two drugs: telitacicept and belimumab. The goal was to see which one better protects kidney function and causes fewer side effects. Participants had already been on one of the drugs for at leas…
Sponsor: Yipeng Liu • Aim: Disease control
Last updated May 26, 2026 12:12 UTC